|
1
|
Ranieri VM, Rubenfeld GD, Thompson BT,
Ferguson ND, Caldwell E, Fan E and Camporota L: Acute respiratory
distress syndrome: The Berlin Definition. JAMA. 307:2526–2533.
2012.PubMed/NCBI
|
|
2
|
Phua J, Badia JR, Adhikari NK, Friedrich
JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, et
al: Has mortality from acute respiratory distress syndrome
decreased over time?: A systematic review. Am J Respir Crit Care
Med. 179:220–227. 2009. View Article : Google Scholar
|
|
3
|
Müller-Redetzky HC, Suttorp N and
Witzenrath M: Dynamics of pulmonary endothelial barrier function in
acute inflammation: Mechanisms and therapeutic perspectives. Cell
Tissue Res. 355:657–673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lucas R, Verin AD, Black SM and Catravas
JD: Regulators of endothelial and epithelial barrier integrity and
function in acute lung injury. Biochem Pharmacol. 77:1763–1772.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gong MN, Bajwa EK, Thompson BT and
Christiani DC: Body mass index is associated with the development
of acute respiratory distress syndrome. Thorax. 65:44–50. 2010.
View Article : Google Scholar
|
|
6
|
Anzueto A, Frutos-Vivar F, Esteban A,
Bensalami N, Marks D, Raymondos K, Apezteguía C, Arabi Y, Hurtado
J, González M, et al Ventila group: Influence of body mass index on
outcome of the mechanically ventilated patients. Thorax. 66:66–73.
2011. View Article : Google Scholar
|
|
7
|
Stapleton RD and Suratt BT: Obesity and
nutrition in acute respiratory distress syndrome. Clin Chest Med.
35:655–671. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Konter J, Baez E and Summer RS: Obesity:
'priming' the lung for injury. Pulm Pharmacol Ther. 26:427–429.
2013. View Article : Google Scholar
|
|
9
|
Matsuzawa Y, Funahashi T and Nakamura T:
The concept of metabolic syndrome: Contribution of visceral fat
accumulation and its molecular mechanism. J Atheroscler Thromb.
18:629–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Gaal LF, Mertens IL and De Block CE:
Mechanisms linking obesity with cardiovascular disease. Nature.
444:875–880. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yamawaki H: Mechanisms of action of novel
adipocytokines on the vascular system. Nihon Yakurigaku Zasshi.
137:131–135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mattu HS and Randeva HS: Role of
adipokines in cardiovascular disease. J Endocrinol. 216:T17–T36.
2013. View Article : Google Scholar
|
|
13
|
Ohashi K, Shibata R, Murohara T and Ouchi
N: Role of anti-inflammatory adipokines in obesity-related
diseases. Trends Endocrinol Metab. 25:348–355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang C: Obesity, inflammation, and lung
injury (OILI): The good. Mediators Inflamm. 2014:9784632014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shah D, Romero F, Duong M, Wang N, Paudyal
B, Suratt BT, Kallen CB, Sun J, Zhu Y, Walsh K, et al:
Obesity-induced adipokine imbalance impairs mouse pulmonary
vascular endothelial function and primes the lung for injury. Sci
Rep. 5:113622015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Konter JM, Parker JL, Baez E, Li SZ,
Ranscht B, Denzel M, Little FF, Nakamura K, Ouchi N, Fine A, et al:
Adiponectin attenuates lipopolysaccharide-induced acute lung injury
through suppression of endothelial cell activation. J Immunol.
188:854–863. 2012. View Article : Google Scholar
|
|
17
|
Fan XF, Xue F, Zhang YQ, Xing XP, Liu H,
Mao SZ, Kong XX, Gao YQ, Liu SF and Gong YS: The Apelin-APJ axis is
an endogenous counterinjury mechanism in experimental acute lung
injury. Chest. 147:969–978. 2015. View Article : Google Scholar
|
|
18
|
Qi D, Tang X, He J, Wang D, Zhao Y, Deng
W, Deng X, Zhou G, Xia J, Zhong X, et al: Omentin protects against
LPS-induced ARDS through suppressing pulmonary inflammation and
promoting endothelial barrier via an Akt/eNOS-dependent mechanism.
Cell Death Dis. 7:e23602016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hida K, Wada J, Eguchi J, Zhang H, Baba M,
Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, et al:
Visceral adipose tissue-derived serine protease inhibitor: A unique
insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci
USA. 102:10610–10615. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dimova R and Tankova T: The role of vaspin
in the development of metabolic and glucose tolerance disorders and
atherosclerosis. BioMed Res Int. 2015:8234812015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kobat MA, Celik A, Balin M, Altas Y,
Baydas A, Bulut M, Aydin S, Dagli N, Yavuzkir MF and Ilhan S: The
investigation of serum vaspin level in atherosclerotic coronary
artery disease. J Clin Med Res. 4:110–113. 2012.PubMed/NCBI
|
|
22
|
Aust G, Richter O, Rohm S, Kerner C, Hauss
J, Klöting N, Ruschke K, Kovacs P, Youn BS and Blüher M: Vaspin
serum concentrations in patients with carotid stenosis.
Atherosclerosis. 204:262–266. 2009. View Article : Google Scholar
|
|
23
|
Wang HH and Wang QF: Low vaspin levels are
related to endothelial dysfunction in patients with ankylosing
spondylitis. Braz J Med Biol Res. 49:e52312016. View Article : Google Scholar :
|
|
24
|
Nakatsuka A, Wada J, Iseda I, Teshigawara
S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama
A, et al: Visceral adipose tissue-derived serine proteinase
inhibitor inhibits apoptosis of endothelial cells as a ligand for
the cell-surface GRP78/voltage-dependent anion channel complex.
Circ Res. 112:771–780. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: Vaspin prevents methylglyoxal-induced apoptosis in human
vascular endothelial cells by inhibiting reactive oxygen species
generation. Acta Physiol (Oxf). 209:212–219. 2013.
|
|
26
|
Jung CH, Lee MJ, Kang YM, Lee YL, Yoon HK,
Kang SW, Lee WJ and Park JY: Vaspin inhibits cytokine-induced
nuclear factor-kappa B activation and adhesion molecule expression
via AMP-activated protein kinase activation in vascular endothelial
cells. Cardiovasc Diabetol. 13:412014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jung CH, Lee WJ, Hwang JY, Seol SM, Kim
YM, Lee YL and Park JY: Vaspin protects vascular endothelial cells
against free fatty acid-induced apoptosis through a
phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res
Commun. 413:264–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin Y, Zhuang J, Li H, Zhu G, Zhou S, Li
W, Peng W and Xu Y: Vaspin attenuates the progression of
atherosclerosis by inhibiting ER stress-induced macrophage
apoptosis in apoE/mice. Mol Med Rep. 13:1509–1516. 2016. View Article : Google Scholar
|
|
29
|
National Research Council (US) Institute
for Laboratory Animal Research: Guidance for the description of
animal research in scientific publications. Washington (DC):
National Academies Press (US); 2011
|
|
30
|
Matute-Bello G, Downey G, Moore BB,
Groshong SD, Matthay MA, Slutsky AS and Kuebler WM; Acute Lung
Injury in Animals Study Group: An official American Thoracic
Society workshop report: features and measurements of experimental
acute lung injury in animals. Am J Respir Cell Mol Biol.
44:725–738. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Ryan D, Frohlich S and McLoughlin P:
Pulmonary vascular dysfunction in ARDS. Ann Intensive Care.
4:282014. View Article : Google Scholar
|
|
33
|
Shibata R, Ohashi K, Murohara T and Ouchi
N: The potential of adipokines as therapeutic agents for
cardiovascular disease. Cytokine Growth Factor Rev. 25:483–487.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu S, Dong Y, Wang T, Zhao S, Yang K,
Chen X and Zheng C: Vaspin inhibited proinflammatory cytokine
induced activation of nuclear factor-kappa B and its downstream
molecules in human endothelial EA.hy926 cells. Diabetes Res Clin
Pract. 103:482–488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Taylor NJ and Shawcross DL:
Alpha1-antitrypsin deficiency. N Engl J Med. 361:2102author reply
2102. 2009.PubMed/NCBI
|
|
36
|
Tumen J, Meyrick B, Berry L Jr and Brigham
KL: Antiproteinases protect cultured lung endothelial cells from
endotoxin injury. J Appl Physiol (1985). 65:835–843. 1988.
|
|
37
|
Feng Y, Hu L, Xu Q, Yuan H, Ba L, He Y and
Che H: Cytoprotective role of alpha-1 antitrypsin in vascular
endothelial cell under hypoxia/reoxygenation condition. J
Cardiovasc Pharmacol. 66:96–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stockley RA: The multiple facets of
alpha-1-antitrypsin. Ann Transl Med. 3:1302015.PubMed/NCBI
|
|
39
|
Jie Z, Cai Y, Yang W, Jin M, Zhu W and Zhu
C: Protective effects of alpha 1-antitrypsin on acute lung injury
in rabbits induced by endotoxin. Chin Med J (Engl). 116:1678–1682.
2003.
|
|
40
|
Petrache I, Fijalkowska I, Medler TR,
Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR and Tuder RM:
α-1 antitrypsin inhibits caspase-3 activity, preventing lung
endothelial cell apoptosis. Am J Pathol. 169:1155–1166. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wewers MD, Herzyk DJ and Gadek JE:
Alveolar fluid neutrophil elastase activity in the adult
respiratory distress syndrome is complexed to
alpha-2-macroglobulin. J Clin Invest. 82:1260–1267. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gadek JE and Pacht ER: The interdependence
of lung antioxidants and antiprotease defense in ARDS. Chest.
110(Suppl 6): 273S–277S. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gando S, Kameue T, Matsuda N, Sawamura A,
Hayakawa M and Kato H: Systemic inflammation and disseminated
intravascular coagulation in early stage of ALI and ARDS: Role of
neutrophil and endothelial activation. Inflammation. 28:237–244.
2004. View Article : Google Scholar
|
|
44
|
Meduri GU, Annane D, Chrousos GP, Marik PE
and Sinclair SE: Activation and regulation of systemic inflammation
in ARDS: Rationale for prolonged glucocorticoid therapy. Chest.
136:1631–1643. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: A novel adipocytokine, vaspin inhibits platelet-derived growth
factor-BB-induced migration of vascular smooth muscle cells.
Biochem Biophys Res Commun. 423:844–849. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Phalitakul S, Okada M, Hara Y and Yamawaki
H: Vaspin prevents TNF-α-induced intracellular adhesion molecule-1
via inhibiting reactive oxygen species-dependent NF-κB and PKCθ
activation in cultured rat vascular smooth muscle cells. Pharmacol
Res. 64:493–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kása A, Csortos C and Verin AD:
Cytoskeletal mechanisms regulating vascular endothelial barrier
function in response to acute lung injury. Tissue Barriers.
3:e9744482015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mehta D and Malik AB: Signaling mechanisms
regulating endothelial permeability. Physiol Rev. 86:279–367. 2006.
View Article : Google Scholar
|
|
49
|
Galani V, Tatsaki E, Bai M, Kitsoulis P,
Lekka M, Nakos G and Kanavaros P: The role of apoptosis in the
pathophysiology of Acute Respiratory Distress Syndrome (ARDS): An
up-to-date cell-specific review. Pathol Res Pract. 206:145–150.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lang JD, McArdle PJ, O'Reilly PJ and
Matalon S: Oxidant-antioxidant balance in acute lung injury. Chest.
122(Suppl 6): 314S–320S. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tasaka S, Amaya F, Hashimoto S and
Ishizaka A: Roles of oxidants and redox signaling in the
pathogenesis of acute respiratory distress syndrome. Antioxid Redox
Signal. 10:739–753. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shiizaki S, Naguro I and Ichijo H:
Activation mechanisms of ASK1 in response to various stresses and
its significance in intracellular signaling. Adv Biol Regul.
53:135–144. 2013. View Article : Google Scholar
|
|
53
|
Matsuzawa A, Nishitoh H, Tobiume K, Takeda
K and Ichijo H: Physiological roles of ASK1-mediated signal
transduction in oxidative stress- and endoplasmic reticulum
stress-induced apoptosis: advanced findings from ASK1 knockout
mice. Antioxid Redox Signal. 4:415–425. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Manukyan MC, Weil BR, Wang Y, Abarbanell
AM, Herrmann JL, Poynter JA and Meldrum DR: The phosphoinositide-3
kinase survival signaling mechanism in sepsis. Shock. 34:442–449.
2010. View Article : Google Scholar : PubMed/NCBI
|
